Relationship Between Renal Function and Pharmacokinetics of Apixaban and Clinical Outcome of Apixaban in Thai Non-valvular Atrial Fibrillation Patients

NCT04684732 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 241

Last updated 2021-01-29

No results posted yet for this study

Summary

The purpose of this study is to assess pharmacokinetics and pharmacodynamics of Apixaban and clinical outcome of Apixaban in Thai patients with nonvalvular atrial fibrillation with varying degree of creatinine clearance

Conditions

Sponsors & Collaborators

  • Thammasat University

    collaborator OTHER
  • Chulalongkorn University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-14
Primary Completion
2021-05-31
Completion
2021-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04684732 on ClinicalTrials.gov